United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 899 out of 57,585 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 147,557 | 147,606 |
| Total Cites | 8,841 | 10,124 |
| H-index | 42 | 45 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 102 | 107 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 416 | 466 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 1,046 | 1,181 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,843 | 7,523 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.35 |
| Self-Citation Percentage |
12.67%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 867 out of 54,095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 139,178 | 140,944 |
| Total Cites | 8,361 | 9,614 |
| H-index | 42 | 45 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 99 | 104 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 397 | 447 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 1,006 | 1,140 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,452 | 7,117 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
13.03%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 863 out of 51,411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 136,514 | 140,782 |
| Total Cites | 7,756 | 8,962 |
| H-index | 40 | 43 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 93 | 98 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 362 | 409 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 949 | 1,079 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,980 | 6,615 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
13.46%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 870 out of 49,699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 138,855 | 145,113 |
| Total Cites | 7,439 | 8,605 |
| H-index | 39 | 42 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 80 | 84 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 334 | 377 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 888 | 1,012 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,731 | 6,344 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.36 |
| Self-Citation Percentage |
13.55%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.